Business
Topics also related to Business:
GSK eyes prime FTSE 100 slot for standalone HIV drugs business
LONDON - GlaxoSmithKline , battered by weak U.S. drug sales and a bribery scandal in China, is looking to float its fast-growing HIV drugs business as part of a recovery plan that includes a fresh round of cost cutting.
Recent Business News
Private equity eyes 10 billion-euro Bayer plastics business: sources
FRANKFURT/LONDON - Private equity firms are circling Bayer's 10 billion-euro (7.9 billion British pounds) plastics business, hoping to divert the German drugmaker from its plan to list the division, two people familiar with the matter said on Wednesday.
As virus spreads, insurers exclude Ebola from new policies
- As fear of Ebola infections spreads to developed economies, U.S. and British insurance companies have begun writing Ebola exclusions into standard policies to cover hospitals, event organisers and other businesses vulnerable to local disruptions.
Porsche cashes in on turnaround with consultancy business
BERLIN - Just as sports car fans adore the Porsche 911, so company bosses are in awe of the automaker's industry-leading profit margins, allowing it to develop a consultancy business with a growing list of high-profile clients keen to find out how it's done.
Eyes on growth numbers after BoE minutes hurt sterling
LONDON - Sterling fell around half a percent against a stronger dollar on Wednesday after Bank of England minutes showed policymakers were firmly against raising interest rates when they met earlier this month.
ECB cools speculation over bank health checks ahead of results
MADRID/VIENNA - The European Central Bank cautioned on Wednesday against speculation over the outcome of its stress tests after a media report said at least 11 banks had failed the landmark financial health checks, driving some banking shares lower.
- Europe
- U.S.
- Asia
- Sectors
| DOW | 16,549.21 |  +149.54 |
+0.91% |
| S&P 500 | 1,938.12 |  -3.16 |
-0.16% |
| NASDAQ | 4,407.50 | -11.97 |
-0.27% |
| TR US Index | 170.82 | +1.98 |
+1.17% |
Sector Summary
| Energy | -0.20% |
| Basic Materials | +0.68% |
| Industrials | +0.72% |
| Cyclical Goods & Services | +0.64% |
| Non-Cyclical Goods & Services | +0.02% |
| Financials | +0.24% |
| Healthcare | +0.22% |
| Technology | +0.17% |
| Telecoms | +0.74% |
| Utilities | +0.27% |
Why the U.S. is spending $1 trillion on nukes
The Congressional Budget Office estimates the 10-year costs of maintaining and modernizing our existing arsenal at $355 billion, with another $215 billion slated for "other nuclear-related activities."
Other Reports
- Gold: PRECIOUS-Gold dips from six-week peak as dollar firms, physical demand eases
- Oil Report: UPDATE 1-Private equity eyes $13 bln Bayer plastics business - sources
- British Pound Report: Sterling makes a good start to week, eyes on GDP data, dollar
- US Dollar Report: FOREX-Dollar gains on uptick in U.S. CPI, euro banking concerns
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
